“The Pink Sheet” is a unique publication that delivers expert, in-depth analysis of biopharma regulatory, legislative, legal and business developments — and their bottom-line impact on the industry. Its comprehensive coverage is vital for successful business development and commercialization strategies that drive profits.
The preeminent coverage provided in “The Pink Sheet” draws upon a global team of analysts specializing in regulatory and reimbursement policy, clinical development and commercial policy, plus a VIP network of insiders — regulatory, legislative, legal, industry and financial stakeholders — to offer authoritative insights into the business of biopharma. From marketing to sales to reimbursement, we combine our deep regulatory and business coverage for multi-level perspective that helps you drive company growth, maximize evolving opportunities, minimize risks, and advance your career.
Every week, “The Pink Sheet” delivers comprehensive coverage of:
- Policy developments at FDA and other regulatory agencies
- Analysis of advisory committee actions and trends
- Reimbursement trends and opportunities or problems they present
- The hottest deals around the industry, including M&A, partnering and acquisitions
- Exciting new start-ups
- The latest in R&D, drug development and product approvals
- Insider interviews highlighting the best minds in the industry
- New marketing and advertising campaigns from your competitors
- Industry events from our analysts around the world
- Updates on compliance and manufacturing issues
Your free trial of “The Pink Sheet” will include:
- 4 weekly print issues
- Email updates: Email newsletter delivered to your inbox
- Topical RSS Feeds